A detailed history of Argyle Capital Management Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Argyle Capital Management Inc. holds 127,486 shares of PFE stock, worth $3.36 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares
127,486
Previous 132,571 3.84%
Holding current value
$3.36 Million
Previous $3.71 Million 0.54%
% of portfolio
1.49%
Previous 1.54%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$27.7 - $31.39 $140,854 - $159,618
-5,085 Reduced 3.84%
127,486 $3.69 Million
Q2 2024

Jul 29, 2024

BUY
$25.26 - $29.6 $195,133 - $228,660
7,725 Added 6.19%
132,571 $3.71 Million
Q1 2024

Apr 29, 2024

BUY
$25.89 - $29.73 $195,806 - $224,847
7,563 Added 6.45%
124,846 $3.46 Million
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $520,431 - $675,982
-19,917 Reduced 14.52%
117,283 $3.38 Million
Q2 2023

Jul 27, 2023

SELL
$36.12 - $41.79 $148,344 - $171,631
-4,107 Reduced 2.91%
137,200 $5.03 Million
Q4 2022

Feb 06, 2023

SELL
$41.75 - $54.5 $14,403 - $18,802
-345 Reduced 0.24%
141,307 $7.24 Million
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $8,752 - $10,684
200 Added 0.14%
141,652 $6.2 Million
Q2 2022

Jul 20, 2022

SELL
$46.53 - $55.17 $58,348 - $69,183
-1,254 Reduced 0.88%
141,452 $7.42 Million
Q1 2022

Apr 27, 2022

SELL
$45.75 - $56.69 $296,963 - $367,974
-6,491 Reduced 4.35%
142,706 $7.39 Million
Q4 2021

Jan 25, 2022

SELL
$41.32 - $61.25 $99,168 - $147,000
-2,400 Reduced 1.58%
149,197 $8.81 Million
Q3 2021

Oct 25, 2021

SELL
$39.25 - $50.42 $11,775 - $15,126
-300 Reduced 0.2%
151,597 $6.52 Million
Q3 2020

Oct 27, 2020

SELL
$31.75 - $37.25 $50,800 - $59,600
-1,600 Reduced 1.04%
151,897 $5.58 Million
Q2 2020

Jul 22, 2020

SELL
$30.12 - $36.54 $10,060 - $12,204
-334 Reduced 0.22%
153,497 $5.02 Million
Q1 2020

Apr 27, 2020

BUY
$27.03 - $38.62 $9,055 - $12,937
335 Added 0.22%
153,831 $5.02 Million
Q4 2019

Jan 24, 2020

SELL
$32.92 - $37.36 $13,168 - $14,944
-400 Reduced 0.26%
153,496 $6.01 Million
Q3 2019

Oct 25, 2019

BUY
$32.49 - $42.13 $22,743 - $29,491
700 Added 0.46%
153,896 $5.53 Million
Q2 2019

Jul 25, 2019

BUY
$36.98 - $41.52 $14,791 - $16,608
400 Added 0.26%
153,196 $6.64 Million
Q4 2018

Jan 28, 2019

SELL
$38.47 - $43.86 $76,940 - $87,720
-2,000 Reduced 1.29%
152,796 $6.67 Million
Q3 2018

Oct 26, 2018

SELL
$34.47 - $41.81 $10,030 - $12,166
-291 Reduced 0.19%
154,796 $6.82 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $5,837 - $6,223
-177 Reduced 0.11%
155,087 $5.63 Million
Q1 2018

Apr 25, 2018

SELL
$31.91 - $37.02 $96,017 - $111,393
-3,009 Reduced 1.9%
155,264 $5.51 Million
Q4 2017

Jan 25, 2018

SELL
$33.26 - $35.29 $36,586 - $38,819
-1,100 Reduced 0.69%
158,273 $5.73 Million
Q3 2017

Oct 26, 2017

BUY
$31.0 - $34.15 $4.94 Million - $5.44 Million
159,373
159,373 $5.69 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Argyle Capital Management Inc. Portfolio

Follow Argyle Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Management Inc. with notifications on news.